Ricardo Dias de Castro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ricardo Dias de Castro has a total of 319 co-authors. Here are the top co-authors by number of shared publications:
- Danielle da Nóbrega Alves
Universidade Federal da Paraíba, Brasil
19 shared publications - Damião Pergentino de Sousa
Laboratory of Pharmaceutical Chemistry, Department of Pharmaceutical Sciences Federal University of Paraíba João Pessoa Paraíba Brazil
14 shared publications - Luciana Scotti
Postgraduate Program in Natural Synthetic and Bioactive Products, Health Sciences Center, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil, Brazil
11 shared publications - Marcus Tullius Scotti
Universidade Federal da Paraíba, Brazil
9 shared publications - Reinaldo Nóbrega de Almeida
Universidade Federal da Paraíba, Brazil
7 shared publications - Marianna Vieira Sobral
Postgraduate Program in Bioactive Natural and Synthetic Products, Federal University of Paraíba, João Pessoa 58051-900, PB, Brazil
6 shared publications
Latest Publications
- Open Access
- 18 August 2026
- Published by Elsevier in Archives of Oral Biology
- Vol. 191, 106734
Targeting endocarditis-associated Streptococcus biofilms: The antibacterial potential of Lippia sidoides essential oil
- 18 August 2026
- Published by Elsevier in Archives of Oral Biology
- Vol. 191, 106734
Open AccessTargeting endocarditis-associated Streptococcus biofilms: The antibacterial potential of Lippia sidoides essential oil
- Open Access
- 9 August 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (8) , e71569
Synthetic Sinapates: Antifungal, Molecular Docking, and ADMET Studies
The increasing incidence of diseases resulting from fungal infections is due to the high morbidity and mortality associated with these microorganisms. Sinapic acid is a plant‐derived phenolic compound with antifungal activity. Therefore, in this study, a collection of eleven sinapates ( 1 ‐ 11 ) was prepared and the antifungal activity of these compounds was evaluated against Candida albicans and Candida tropicalis . Compounds 4 , 5 , and 8 showed good antifungal activity. Compound 4 presented minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) values of 62.5 µg/mL against C. albicans and 15.62 µg/mL against C. tropicalis . Compound 5 showed MIC and MFC values of 7.81 µg/mL against both strains, while compound 8 presented MIC and MFC values of 15.62 µg/mL against C. albicans and 62.5 µg/mL against C. tropicalis . The ratio MFC/MICCandida drug candidates.
- 9 August 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (8) , e71569
Open AccessSynthetic Sinapates: Antifungal, Molecular Docking, and ADMET Studies
The increasing incidence of diseases resulting from fungal infections is due to the high morbidity and mortality associated with these microorganisms. Sinapic acid is a plant‐derived phenolic compound with antifungal activity. Therefore, in this study, a collection of eleven sinapates ( 1 ‐ 11 ) was prepared and the antifungal activity of these compounds was evaluated against Candida albicans and Candida tropicalis . Compounds 4 , 5 , and 8 showed good antifungal activity. Compound 4 presented minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) values of 62.5 µg/mL against C. albicans and 15.62 µg/mL against C. tropicalis . Compound 5 showed MIC and MFC values of 7.81 µg/mL against both strains, while compound 8 presented MIC and MFC values of 15.62 µg/mL against C. albicans and 62.5 µg/mL against C. tropicalis . The ratio MFC/MICCandida drug candidates.
- Open Access
- 28 June 2026
- Published by Wiley in International Journal of Ceramic Engineering & Science
- Vol. 8 (4)
Manganese‐Doped Mesoporous Bioactive Glasses
Bioactive glasses have emerged as promising biomaterials due to their ability to promote osseointegration and accelerate bone regeneration. This study investigates the formulation and characterization of manganese (Mn)‐doped 85S mesoporous bioactive glass (85SiO 2 –(15 − x )CaO– x MnO mol%, x = 1, 2, 3, and 4). Morphological and structural analyses confirmed the amorphous and mesoporous structure of the microsized glass particles, showing average pore sizes of 2 nm. Bioactivity was evaluated in vitro in simulated body fluid (SBF), demonstrating the formation of a hydroxycarbonate apatite (HCA) layer on the surfaces, as evidenced by x‐ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM). Cytotoxicity was assessed in vitro using the MTT (3‐[4,5‐dimethylthiazol‐2‐yl]‐2,5‐diphenyltetrazolium bromide) assay, revealing that Mn‐doped glasses exhibited no significant cytotoxicity, indicating biocompatibility. Antimicrobial and antifungal properties were also evaluated. The results indicate a composition‐dependent effect of Mn, with 0–2 mol% Mn preserving mesoporosity, sustaining rapid HCA formation, and ensuring cytocompatibility. Within this range, particularly at 2 mol% Mn, the glasses exhibit enhanced antibacterial activity against selected strains, whereas strong antifungal effects are mainly associated with undoped 85S and 1 mol% Mn. In contrast, higher Mn contents (3–4 mol%) reduce specific surface area, delay or suppress HCA formation, and do not provide superior antimicrobial performance. Altogether, these findings define 1–2 mol% Mn as an optimal doping window, highlighting the trade‐off among structural features, bioactivity, and antimicrobial efficacy.
- 28 June 2026
- Published by Wiley in International Journal of Ceramic Engineering & Science
- Vol. 8 (4)
Open AccessManganese‐Doped Mesoporous Bioactive Glasses
Bioactive glasses have emerged as promising biomaterials due to their ability to promote osseointegration and accelerate bone regeneration. This study investigates the formulation and characterization of manganese (Mn)‐doped 85S mesoporous bioactive glass (85SiO 2 –(15 − x )CaO– x MnO mol%, x = 1, 2, 3, and 4). Morphological and structural analyses confirmed the amorphous and mesoporous structure of the microsized glass particles, showing average pore sizes of 2 nm. Bioactivity was evaluated in vitro in simulated body fluid (SBF), demonstrating the formation of a hydroxycarbonate apatite (HCA) layer on the surfaces, as evidenced by x‐ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM). Cytotoxicity was assessed in vitro using the MTT (3‐[4,5‐dimethylthiazol‐2‐yl]‐2,5‐diphenyltetrazolium bromide) assay, revealing that Mn‐doped glasses exhibited no significant cytotoxicity, indicating biocompatibility. Antimicrobial and antifungal properties were also evaluated. The results indicate a composition‐dependent effect of Mn, with 0–2 mol% Mn preserving mesoporosity, sustaining rapid HCA formation, and ensuring cytocompatibility. Within this range, particularly at 2 mol% Mn, the glasses exhibit enhanced antibacterial activity against selected strains, whereas strong antifungal effects are mainly associated with undoped 85S and 1 mol% Mn. In contrast, higher Mn contents (3–4 mol%) reduce specific surface area, delay or suppress HCA formation, and do not provide superior antimicrobial performance. Altogether, these findings define 1–2 mol% Mn as an optimal doping window, highlighting the trade‐off among structural features, bioactivity, and antimicrobial efficacy.
- Open Access
- 27 April 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (4) , e03228
Antinociceptive Effect of Cinnamaldehyde in Male Mice: Investigation of the Mechanisms of Action Through In Silico and In Vivo Approaches
Cinnamaldehyde (CA), a major component of Cinnamomum spp. essential oils, has recognized bioactivity, including possible analgesic effects. However, its acute antinociceptive mechanisms remain unclear. This study assessed the influence of CA (15, 30, and 60 mg/kg, p.o.) on locomotor and exploratory behaviors via rotarod and open field tests in male Swiss mice. Antinociceptive activity was evaluated using chemical and thermal nociception models. Mechanistic investigations were performed in the opioid and adrenergic systems, as well as in silico molecular docking in nociceptive targets. A significance level of p = 0.01 was adopted. CA significantly reduced nociceptive behaviors in all models without impairing motor coordination. In the formalin test, it inhibited neurogenic and inflammatory phases. In glutamate and capsaicin tests, CA markedly reduced nociceptive responses. In the hot plate test, it increased latency at 30 mg/kg. Naloxone reversed the antinociceptive effect of CA in the formalin test, supporting the hypothesis of opioid receptor involvement, while yohimbine partially blocked the response, suggesting α 2 ‐adrenergic contribution. Docking simulations showed favorable interactions of CA with κ‐ and δ‐opioid receptors, NMDA, AMPA, and TRPV1, supporting a multimodal mechanism. CA displays acute antinociceptive activity, and the findings suggest the involvement of central pathways, including opioid and adrenergic systems.
- 27 April 2026
- Published by Wiley in Chemistry & Biodiversity
- Vol. 23 (4) , e03228
Open AccessAntinociceptive Effect of Cinnamaldehyde in Male Mice: Investigation of the Mechanisms of Action Through In Silico and In Vivo Approaches
Cinnamaldehyde (CA), a major component of Cinnamomum spp. essential oils, has recognized bioactivity, including possible analgesic effects. However, its acute antinociceptive mechanisms remain unclear. This study assessed the influence of CA (15, 30, and 60 mg/kg, p.o.) on locomotor and exploratory behaviors via rotarod and open field tests in male Swiss mice. Antinociceptive activity was evaluated using chemical and thermal nociception models. Mechanistic investigations were performed in the opioid and adrenergic systems, as well as in silico molecular docking in nociceptive targets. A significance level of p = 0.01 was adopted. CA significantly reduced nociceptive behaviors in all models without impairing motor coordination. In the formalin test, it inhibited neurogenic and inflammatory phases. In glutamate and capsaicin tests, CA markedly reduced nociceptive responses. In the hot plate test, it increased latency at 30 mg/kg. Naloxone reversed the antinociceptive effect of CA in the formalin test, supporting the hypothesis of opioid receptor involvement, while yohimbine partially blocked the response, suggesting α 2 ‐adrenergic contribution. Docking simulations showed favorable interactions of CA with κ‐ and δ‐opioid receptors, NMDA, AMPA, and TRPV1, supporting a multimodal mechanism. CA displays acute antinociceptive activity, and the findings suggest the involvement of central pathways, including opioid and adrenergic systems.
- Open Access
- 11 March 2026
- Published by Elsevier in Archives of Oral Biology
- Vol. 186, 106572
Lippia sidoides essential oil against Candida auris and Candida albicans – A promising strategy for antifungal activity in the context of oral candidiasis
- 11 March 2026
- Published by Elsevier in Archives of Oral Biology
- Vol. 186, 106572
Open AccessLippia sidoides essential oil against Candida auris and Candida albicans – A promising strategy for antifungal activity in the context of oral candidiasis
- Open Access
- 25 December 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (1) , 27
Microglia-Targeted Nanotherapeutics in Major Depressive Disorder: An Integrative Perspective on Neuroinflammation and Drug Delivery
Major depressive disorder (MDD) is a highly prevalent psychiatric condition characterized by complex neurobiological mechanisms, including oxidative stress and neuroinflammation, with microglial activation playing a key role in its pathophysiology. Conventional antidepressants, though widely used, often fail to achieve remission due to limited efficacy, adverse effects, and poor patient adherence. In this context, nanotechnology-based drug delivery systems have emerged as promising strategies to overcome pharmacological limitations, enhance blood–brain barrier (BBB) penetration, and target neuroinflammatory pathways. This narrative review explores the role of microglia as both mediators of neuroinflammation and potential therapeutic targets in MDD. We examine different nanocarriers and their ability to modulate microglial activation, promote a shift from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype, and enhance antidepressant efficacy. Preclinical studies have demonstrated that nanoparticle-based systems not only improve drug bioavailability and brain targeting but also potentiate neuroprotective effects by reducing oxidative stress, promoting neurogenesis, and restoring synaptic plasticity. These findings highlight the potential of nanotechnology as a novel approach to precision neuropsychopharmacology. This review aims to provide an integrative perspective on how nanocarrier-based strategies targeting microglia could redefine future therapeutic paradigms for MDD.
- 25 December 2025
- Published by MDPI AG in Pharmaceutics
- Vol. 18 (1) , 27
Open AccessMicroglia-Targeted Nanotherapeutics in Major Depressive Disorder: An Integrative Perspective on Neuroinflammation and Drug Delivery
Major depressive disorder (MDD) is a highly prevalent psychiatric condition characterized by complex neurobiological mechanisms, including oxidative stress and neuroinflammation, with microglial activation playing a key role in its pathophysiology. Conventional antidepressants, though widely used, often fail to achieve remission due to limited efficacy, adverse effects, and poor patient adherence. In this context, nanotechnology-based drug delivery systems have emerged as promising strategies to overcome pharmacological limitations, enhance blood–brain barrier (BBB) penetration, and target neuroinflammatory pathways. This narrative review explores the role of microglia as both mediators of neuroinflammation and potential therapeutic targets in MDD. We examine different nanocarriers and their ability to modulate microglial activation, promote a shift from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype, and enhance antidepressant efficacy. Preclinical studies have demonstrated that nanoparticle-based systems not only improve drug bioavailability and brain targeting but also potentiate neuroprotective effects by reducing oxidative stress, promoting neurogenesis, and restoring synaptic plasticity. These findings highlight the potential of nanotechnology as a novel approach to precision neuropsychopharmacology. This review aims to provide an integrative perspective on how nanocarrier-based strategies targeting microglia could redefine future therapeutic paradigms for MDD.
- Open Access
- 1 December 2025
- Published by MDPI AG in Future Pharmacology
- Vol. 5 (4) , 71
Antibacterial Mechanisms of 4-Chlorobenzyl p-Coumarate: Inhibition of MepA and NorA Efflux Pumps
Introduction: Bacterial infections, especially those caused by multidrug-resistant strains, remain a major health concern. This study investigates 4-chlorobenzyl p-coumarate, assessing its antibacterial mechanism, pharmacokinetic profile, and potential to modulate antimicrobial resistance. Methods: In silico studies were conducted, including molecular docking, molecular dynamics simulations, and pharmacokinetic predictions, alongside in vitro assays assessing efflux pump inhibition, antibiotic modulation, and bacterial DNA analysis. Results: The compound showed higher binding affinity and complex stability with the enzyme phosphatidylglycerol phosphate synthase, while also exhibiting reduced residue fluctuations and better flexibility with the NAD+-dependent DNA ligase. Molecular interactions with the efflux proteins MepA and NorA were also observed. Pharmacokinetic predictions indicated a favorable profile, including suitability for oral administration. Experimentally, the compound inhibited the MepA and NorA efflux pumps, modulated the activity of the antibiotics ciprofloxacin and norfloxacin, and reduced DNA concentration in treated cells. Conclusions: The findings suggest that the compound acts through dual mechanisms, with a prediction of activity by disrupting phosphatidylglycerol synthesis and DNA replication while inhibiting and modulating MepA and NorA efflux pumps.
- 1 December 2025
- Published by MDPI AG in Future Pharmacology
- Vol. 5 (4) , 71
Open AccessAntibacterial Mechanisms of 4-Chlorobenzyl p-Coumarate: Inhibition of MepA and NorA Efflux Pumps
Introduction: Bacterial infections, especially those caused by multidrug-resistant strains, remain a major health concern. This study investigates 4-chlorobenzyl p-coumarate, assessing its antibacterial mechanism, pharmacokinetic profile, and potential to modulate antimicrobial resistance. Methods: In silico studies were conducted, including molecular docking, molecular dynamics simulations, and pharmacokinetic predictions, alongside in vitro assays assessing efflux pump inhibition, antibiotic modulation, and bacterial DNA analysis. Results: The compound showed higher binding affinity and complex stability with the enzyme phosphatidylglycerol phosphate synthase, while also exhibiting reduced residue fluctuations and better flexibility with the NAD+-dependent DNA ligase. Molecular interactions with the efflux proteins MepA and NorA were also observed. Pharmacokinetic predictions indicated a favorable profile, including suitability for oral administration. Experimentally, the compound inhibited the MepA and NorA efflux pumps, modulated the activity of the antibiotics ciprofloxacin and norfloxacin, and reduced DNA concentration in treated cells. Conclusions: The findings suggest that the compound acts through dual mechanisms, with a prediction of activity by disrupting phosphatidylglycerol synthesis and DNA replication while inhibiting and modulating MepA and NorA efflux pumps.
- Open Access
- 28 July 2025
- Published by MDPI AG in Preprints.org
Targeting Microglia Via Nanotechnology: A Novel Strategy to Overcome Neuroinflammation in Major Depressive Disorder
Major Depressive Disorder (MDD) is a highly prevalent psychiatric condition characterized by complex neurobiological mechanisms, including oxidative stress and neuroinflammation, with microglial activation playing a key role in its pathophysiology. Conventional antidepressants, though widely used, often fail to achieve remission due to limited efficacy, adverse effects, and poor patient adherence. In this context, nanotechnology-based drug delivery systems have emerged as promising strategies to overcome pharmacological limitations, enhance blood–brain barrier penetration, and target neuroinflammatory pathways. This narrative review explores the role of microglia as both mediators of neuroinflammation and potential therapeutic targets in MDD. We examine different nanocarriers — such as polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, dendrimers, magnetic nanoparticles, and liposomes — and their ability to modulate microglial activation, promote a shift from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype, and enhance antidepressant efficacy. Preclinical studies have demonstrated that nanoparticle-based systems not only improve drug bioavailability and brain targeting but also potentiate neuroprotective effects by reducing oxidative stress, promoting neurogenesis, and restoring synaptic plasticity. These findings highlight the potential of nanotechnology as a novel approach to precision neuropsychopharmacology. This review aims to provide an integrative perspective on how nanocarrier-based strategies targeting microglia could redefine future therapeutic paradigms for MDD.
- 28 July 2025
- Published by MDPI AG in Preprints.org
Open AccessTargeting Microglia Via Nanotechnology: A Novel Strategy to Overcome Neuroinflammation in Major Depressive Disorder
Major Depressive Disorder (MDD) is a highly prevalent psychiatric condition characterized by complex neurobiological mechanisms, including oxidative stress and neuroinflammation, with microglial activation playing a key role in its pathophysiology. Conventional antidepressants, though widely used, often fail to achieve remission due to limited efficacy, adverse effects, and poor patient adherence. In this context, nanotechnology-based drug delivery systems have emerged as promising strategies to overcome pharmacological limitations, enhance blood–brain barrier penetration, and target neuroinflammatory pathways. This narrative review explores the role of microglia as both mediators of neuroinflammation and potential therapeutic targets in MDD. We examine different nanocarriers — such as polymeric nanoparticles, solid lipid nanoparticles, nanostructured lipid carriers, dendrimers, magnetic nanoparticles, and liposomes — and their ability to modulate microglial activation, promote a shift from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype, and enhance antidepressant efficacy. Preclinical studies have demonstrated that nanoparticle-based systems not only improve drug bioavailability and brain targeting but also potentiate neuroprotective effects by reducing oxidative stress, promoting neurogenesis, and restoring synaptic plasticity. These findings highlight the potential of nanotechnology as a novel approach to precision neuropsychopharmacology. This review aims to provide an integrative perspective on how nanocarrier-based strategies targeting microglia could redefine future therapeutic paradigms for MDD.
- 1 April 2025
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 136 (4)
Synthesis, antimicrobial activity, and toxicological evaluation of a p-coumaric acid derivative as a potential new antibacterial agent
Aims: Bacterial infections have a profound impact on human health and require continuous development of medical treatments. They remain an important area of research due to their ability to adapt and develop resistance to available therapies. This research aims to identify an additional molecule as a potential future option for the treatment of bacterial infections. Methods and results: 4-Chlorobenzyl p-coumarate was tested to evaluate its activity against bacterial strains in both planktonic and biofilm forms, its possible mode of action, and its toxicity through in silico, in vitro, and in vivo approaches. The molecule exhibited significant activity against Gram-positive bacteria leading to their elimination within 24 h. It induced morphological alterations on the surface and within the cells, ultimately causing cell lysis. The compound reduced bacterial biofilm, penetrated the extracellular matrix, and reached cells within the biofilm, disrupting its architecture. Toxicological assessments in predictive models were promising, showing low cytotoxic effects on human cells and no systemic toxicity. Conclusions: 4-Chlorobenzyl p-coumarate proved to be a promising compound for proposing new investigative hypotheses considering its effect on multidrug-resistant and non-resistant Gram-positive bacteria.
- 1 April 2025
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 136 (4)
Synthesis, antimicrobial activity, and toxicological evaluation of a p-coumaric acid derivative as a potential new antibacterial agent
Aims: Bacterial infections have a profound impact on human health and require continuous development of medical treatments. They remain an important area of research due to their ability to adapt and develop resistance to available therapies. This research aims to identify an additional molecule as a potential future option for the treatment of bacterial infections. Methods and results: 4-Chlorobenzyl p-coumarate was tested to evaluate its activity against bacterial strains in both planktonic and biofilm forms, its possible mode of action, and its toxicity through in silico, in vitro, and in vivo approaches. The molecule exhibited significant activity against Gram-positive bacteria leading to their elimination within 24 h. It induced morphological alterations on the surface and within the cells, ultimately causing cell lysis. The compound reduced bacterial biofilm, penetrated the extracellular matrix, and reached cells within the biofilm, disrupting its architecture. Toxicological assessments in predictive models were promising, showing low cytotoxic effects on human cells and no systemic toxicity. Conclusions: 4-Chlorobenzyl p-coumarate proved to be a promising compound for proposing new investigative hypotheses considering its effect on multidrug-resistant and non-resistant Gram-positive bacteria.
- 16 February 2025
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 29 (2) , 1-14
Ion release, cytocompatibility and microbial inhibition of a novel varnish containing fluoride-doped bioactive glass ceramics: an in vitro study
Objectives The study aimed to develop and evaluate in vitro a varnish containing fluoride-doped glass ceramics capable of inhibiting oral microorganisms, releasing hydroxyapatite-forming ions, and ensuring biocompatibility. Materials and methods For the production of the experimental varnish (VE), composed of hydrogenated rosin, 10% and 20% by weight of glass ceramics with composition S53P4 (CF0) and doped with Fˉ ions (CF5 and CF10) were incorporated. The EVs were characterized by Rheology, Scanning Electron Microscopy (SEM), FTIR, ion release (fluoride and calcium ions), cytotoxicity on VERO cells, and antimicrobial effect on S. mutans, S. aureus and C. albicans and anti-biofilm effect on S. mutans. The data were analyzed by One-Way ANOVA and Kruskal–Wallis test (P = 0.05). Results Homogeneous varnishes with good viscosity were obtained. Varnishes with 20% CF demonstrated biocompatibility and minimum inhibitory concentration (MIC) at concentrations lower than 10 mg/mL and 3.12 mg/mL, respectively, except for C. albicans. An anti-biofilm effect on S. mutans was observed for the varnishes with 20% CF. All varnishes with CF released more Fˉ than the commercial varnish, with V20CF10 standing out, which released 4 times more Fˉ ions in a quarter of the time. Conclusions The V20CF10 varnish is a promising material for dental use in the treatment of early caries lesions, due to its biocompatibility, antimicrobial properties, and release of hydroxyapatite-forming ions. Clinical relevance. The use of a new varnish that combines antimicrobial properties with hydroxyapatite-forming ion release may prevent or halt the progression of dental caries lesions, offering greater efficacy than currently available varnishes.
- 16 February 2025
- Published by Springer Nature in Clinical Oral Investigations
- Vol. 29 (2) , 1-14
Ion release, cytocompatibility and microbial inhibition of a novel varnish containing fluoride-doped bioactive glass ceramics: an in vitro study
Objectives The study aimed to develop and evaluate in vitro a varnish containing fluoride-doped glass ceramics capable of inhibiting oral microorganisms, releasing hydroxyapatite-forming ions, and ensuring biocompatibility. Materials and methods For the production of the experimental varnish (VE), composed of hydrogenated rosin, 10% and 20% by weight of glass ceramics with composition S53P4 (CF0) and doped with Fˉ ions (CF5 and CF10) were incorporated. The EVs were characterized by Rheology, Scanning Electron Microscopy (SEM), FTIR, ion release (fluoride and calcium ions), cytotoxicity on VERO cells, and antimicrobial effect on S. mutans, S. aureus and C. albicans and anti-biofilm effect on S. mutans. The data were analyzed by One-Way ANOVA and Kruskal–Wallis test (P = 0.05). Results Homogeneous varnishes with good viscosity were obtained. Varnishes with 20% CF demonstrated biocompatibility and minimum inhibitory concentration (MIC) at concentrations lower than 10 mg/mL and 3.12 mg/mL, respectively, except for C. albicans. An anti-biofilm effect on S. mutans was observed for the varnishes with 20% CF. All varnishes with CF released more Fˉ than the commercial varnish, with V20CF10 standing out, which released 4 times more Fˉ ions in a quarter of the time. Conclusions The V20CF10 varnish is a promising material for dental use in the treatment of early caries lesions, due to its biocompatibility, antimicrobial properties, and release of hydroxyapatite-forming ions. Clinical relevance. The use of a new varnish that combines antimicrobial properties with hydroxyapatite-forming ion release may prevent or halt the progression of dental caries lesions, offering greater efficacy than currently available varnishes.